Advertisement
  • Does Medicaid Expansion Have an Impact?

    Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.

    by Marci A. Landsmann

  • Achieving Health Equality

    National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.

    by Marci A. Landsmann

  • Vaccinating Against Cancer

    The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?

    by Brad Jones

  • A New Guideline for Cervical Cancer Screening

    Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.

    by Anna Azvolinsky

  • Will Right to Try Increase Access to Experimental Treatments?

    The recently passed Right to Try Act is meant to provide patients with greater access to experimental therapies. Patient advocates are divided on whether the law will benefit patients.

    by Marci A. Landsmann

  • Bill Aims to Improve Childhood Cancer Research

    The STAR Act passes in the U.S. House of Representatives.

    by Brad Jones

  • Talking About Medical Marijuana

    Medical oncologists discuss marijuana with their patients. Many of these doctors feel they aren't well enough informed to make recommendations about it, but some do anyway.

    by Kate Yandell

  • Paying for Tumor Testing

    A recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.

    by Brad Jones

  • A New Type of Drug Approval

    At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

    by Kate Yandell

  • Patient Advocates Go to Washington

    Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.

    by Marci A. Landsmann